Correlation Between Pasithea Therapeutics and BioAffinity Technologies,

Can any of the company-specific risk be diversified away by investing in both Pasithea Therapeutics and BioAffinity Technologies, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pasithea Therapeutics and BioAffinity Technologies, into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Pasithea Therapeutics Corp and bioAffinity Technologies,, you can compare the effects of market volatilities on Pasithea Therapeutics and BioAffinity Technologies, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pasithea Therapeutics with a short position of BioAffinity Technologies,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pasithea Therapeutics and BioAffinity Technologies,.

Diversification Opportunities for Pasithea Therapeutics and BioAffinity Technologies,

-0.27

Correlation Coefficient

Pasithea Therapeutics  BioAffinity Technologies,

Very good diversification

The 3 months correlation between Pasithea and BioAffinity is -0.27. Overlapping area represents the amount of risk that can be diversified away by holding Pasithea Therapeutics Corp and bioAffinity Technologies, in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on bioAffinity Technologies, and Pasithea Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pasithea Therapeutics Corp are associated (or correlated) with BioAffinity Technologies,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of bioAffinity Technologies, has no effect on the direction of Pasithea Therapeutics i.e., Pasithea Therapeutics and BioAffinity Technologies, go up and down completely randomly.

Pair Corralation between Pasithea Therapeutics and BioAffinity Technologies,

Given the investment horizon of 90 days Pasithea Therapeutics Corp is expected to generate 0.27 times more return on investment than BioAffinity Technologies,. However, Pasithea Therapeutics Corp is 3.71 times less risky than BioAffinity Technologies,. It trades about 0.06 of its potential returns per unit of risk. bioAffinity Technologies, is currently generating about -0.1 per unit of risk. If you would invest  72.00  in Pasithea Therapeutics Corp on July 6, 2025 and sell it today you would earn a total of  7.00  from holding Pasithea Therapeutics Corp or generate 9.72% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Pasithea Therapeutics Corp  vs.  bioAffinity Technologies,

Pasithea Therapeutics

Risk-Adjusted Performance

Soft

Compared to the overall equity markets, risk-adjusted returns on investments in Pasithea Therapeutics Corp are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Despite somewhat inconsistent basic indicators, Pasithea Therapeutics may actually be approaching a critical reversion point that can send shares even higher in November 2025.

bioAffinity Technologies,

Risk-Adjusted Performance

Weakest

Over the last 90 days bioAffinity Technologies, has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fragile performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in November 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

Pair Trading with Pasithea Therapeutics and BioAffinity Technologies,

The main advantage of trading using opposite Pasithea Therapeutics and BioAffinity Technologies, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pasithea Therapeutics position performs unexpectedly, BioAffinity Technologies, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BioAffinity Technologies, will offset losses from the drop in BioAffinity Technologies,'s long position.

The idea behind Pasithea Therapeutics Corp and bioAffinity Technologies, pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.